{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T06:32:31Z","timestamp":1778999551245,"version":"3.51.4"},"reference-count":27,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.4158\/ep14243.or","type":"journal-article","created":{"date-parts":[[2015,2,9]],"date-time":"2015-02-09T21:54:27Z","timestamp":1423518867000},"page":"567-573","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["DPP-4 Inhibitor Therapy in Patients after Pancreatic Transplant"],"prefix":"10.1016","volume":"21","author":[{"given":"Ahmet B.","family":"Ergin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emilio","family":"Poggio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Venkatesh","family":"Krishnamurthi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tania","family":"Jaber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Betul A.","family":"Hatipoglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.4158\/EP14243.OR_bb0010","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1097\/01.TP.0000079457.43199.76","article-title":"Chronic rejection: The next major challenge for pancreas transplant recipients","volume":"76","author":"Humar","year":"2003","journal-title":"Transplantation"},{"key":"10.4158\/EP14243.OR_bb0015","first-page":"23","article-title":"Pancreas transplant outcomes for United States and non United States cases as reported to the United Network for Organ Sharing and the International Pancreas Transplant Registry as of December 2011","author":"Gruessner","year":"2012","journal-title":"Clin Transpl"},{"key":"10.4158\/EP14243.OR_bb0020","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1600-6143.2007.02018.x","article-title":"Posttransplant diabetes mellitus after pancreas transplantation","volume":"8","author":"Dean","year":"2008","journal-title":"Am J Transplant"},{"key":"10.4158\/EP14243.OR_bb0025","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.2337\/diacare.25.12.2207","article-title":"Fasting blood sample-based assessment of insulin sensitivity in kidney-pancreas-transplanted patients","volume":"25","author":"Perseghin","year":"2002","journal-title":"Diabetes Care"},{"key":"10.4158\/EP14243.OR_bb0030","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1111\/j.1399-0012.1996.tb00748.x","article-title":"Type II diabetes after combined kidney and pancreas transplantation for type I diabetes mellitus and end-stage renal disease","volume":"10","author":"Jones","year":"1996","journal-title":"Clin Transplant"},{"key":"10.4158\/EP14243.OR_bb0035","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1097\/TP.0b013e3182347ea4","article-title":"Sitagliptin therapy in kidney transplant recipients with new-onset diabetes after transplantation","volume":"92","author":"Lane","year":"2011","journal-title":"Transplantation"},{"key":"10.4158\/EP14243.OR_bb0040","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1097\/TP.0b013e318276a20e","article-title":"Vildagliptin and pioglitazone in patients with impaired glucose tolerance after kidney transplantation: A randomized, placebo-controlled clinical trial","volume":"95","author":"Werzowa","year":"2013","journal-title":"Transplantation"},{"key":"10.4158\/EP14243.OR_bb0045","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1111\/j.1600-6143.2006.01250.x","article-title":"Repaglinide in the management of new-onset diabetes mellitus after renal transplantation","volume":"6","author":"Turk","year":"2006","journal-title":"Am J Transplant"},{"key":"10.4158\/EP14243.OR_bb0050","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1900\/RDS.2011.8.6","article-title":"2011 update on pancreas transplantation: Comprehensive trend analysis of 25,000 cases followed up over the course of twenty-four years at the international pancreas transplant registry (IPTR)","volume":"8","author":"Gruessner","year":"2011","journal-title":"Rev Diabet Stud"},{"key":"10.4158\/EP14243.OR_bb0055","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1097\/00007890-200106150-00013","article-title":"Prediction of the long-term metabolic success of the pancreatic graft function","volume":"71","author":"Battezzati","year":"2001","journal-title":"Transplantation"},{"key":"10.4158\/EP14243.OR_bb0060","doi-asserted-by":"crossref","first-page":"927","DOI":"10.2337\/diabetes.48.4.927","article-title":"Hyperglycemia causes oxidative stress in pancreatic beta-cells of GK rats, a model of type 2 diabetes","volume":"48","author":"Ihara","year":"1999","journal-title":"Diabetes"},{"key":"10.4158\/EP14243.OR_bb0065","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.2337\/diabetes.50.8.1683","article-title":"Glucose induces beta-cell apoptosis via upregulation of the Fas receptor in human islets","volume":"50","author":"Maedler","year":"2001","journal-title":"Diabetes"},{"key":"10.4158\/EP14243.OR_bb0070","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1097\/01.TP.0000098821.26466.DE","article-title":"Postoperative oral glucose tolerance and stimulated insulin secretion: A predictor of endocrine graft function more than 10 years after pancreas-kidney transplantation","volume":"76","author":"Pfeffer","year":"2003","journal-title":"Transplantation"},{"key":"10.4158\/EP14243.OR_bb0075","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1097\/00007890-199802150-00014","article-title":"Diabetes mellitus after renal transplantation: As deleterious as non-transplant-associated diabetes?","volume":"65","author":"Miles","year":"1998","journal-title":"Transplantation"},{"key":"10.4158\/EP14243.OR_bb0080","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/00006676-200307000-00005","article-title":"Immunological characteristics of pancreas transplantation: Review and our experimental experience","volume":"27","author":"Ito","year":"2003","journal-title":"Pancreas"},{"key":"10.4158\/EP14243.OR_bb0085","doi-asserted-by":"crossref","first-page":"805","DOI":"10.2337\/diacare.27.3.805","article-title":"New-Onset Diabetes After Transplantation 2003 International Consensus Guidelines: An endocrinologist's view","volume":"27","author":"International Expert Panel on New-Onset Diabetes after Transplantation","year":"2004","journal-title":"Diabetes Care"},{"key":"10.4158\/EP14243.OR_bb0090","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1592\/phco.2005.25.6.810","article-title":"Secondary failure rates associated with metformin and sulfonylurea therapy for type 2 diabetes mellitus","volume":"25","author":"Eurich","year":"2005","journal-title":"Pharmacotherapy"},{"key":"10.4158\/EP14243.OR_bb0095","doi-asserted-by":"crossref","first-page":"995","DOI":"10.2337\/diacare.28.5.995","article-title":"Glycemic control continues to deteriorate after sulfonylureas are added to metformin among patients with type 2 diabetes","volume":"28","author":"Cook","year":"2005","journal-title":"Diabetes Care"},{"key":"10.4158\/EP14243.OR_bb0100","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/ncpendmet0017","article-title":"Biologic actions and therapeutic potential of the proglucagon-derived peptides","volume":"1","author":"Drucker","year":"2005","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"10.4158\/EP14243.OR_bb0105","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1345\/aph.1R444","article-title":"Evaluating second-line treatment options for type 2 diabetes: Focus on secondary effects of GLP-1 agonists and DPP-4 inhibitors","volume":"47","author":"Boland","year":"2013","journal-title":"Ann Pharmacother"},{"key":"10.4158\/EP14243.OR_bb0110","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.2337\/db05-1602","article-title":"Chronic inhibition of dipeptidyl peptidase-4 with a sitagliptin analog preserves pancreatic beta-cell mass and function in a rodent model of type 2 diabetes","volume":"55","author":"Mu","year":"2006","journal-title":"Diabetes"},{"key":"10.4158\/EP14243.OR_bb0115","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1530\/eje.0.1460717","article-title":"Long-term inhibition of dipeptidyl peptidase IV improves glucose tolerance and preserves islet function in mice","volume":"146","author":"Reimer","year":"2002","journal-title":"Eur J Endocrinol"},{"issue":"Suppl 4","key":"10.4158\/EP14243.OR_bb0120","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1463-1326.2008.00939.x","article-title":"Relationship between betacell mass and diabetes onset","volume":"10","author":"Matveyenko","year":"2008","journal-title":"Diabetes Obes Metab"},{"key":"10.4158\/EP14243.OR_bb0125","doi-asserted-by":"crossref","first-page":"102","DOI":"10.2337\/diabetes.52.1.102","article-title":"Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes","volume":"52","author":"Butler","year":"2003","journal-title":"Diabetes"},{"key":"10.4158\/EP14243.OR_bb0130","doi-asserted-by":"crossref","first-page":"412","DOI":"10.2337\/dc10-1677","article-title":"Glucagon-like peptide-1 receptor agonist treatment prevents glucocorticoid-induced glucose intolerance and islet-cell dysfunction in humans","volume":"34","author":"van Raalte","year":"2011","journal-title":"Diabetes Care"},{"key":"10.4158\/EP14243.OR_bb0135","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.2337\/db05-1220","article-title":"Dexamethasone induces cell death in insulin-secreting cells, an effect reversed by exendin-4","volume":"55","author":"Ranta","year":"2006","journal-title":"Diabetes"},{"key":"10.4158\/EP14243.OR_bb0140","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1097\/TP.0b013e3181ea67a1","article-title":"Cytomegalovirus mismatch as major risk factor for delayed graft function after pancreas transplantation","volume":"90","author":"Maglione","year":"2010","journal-title":"Transplantation"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20356615?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20356615?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/aace.metapress.com\/index\/Q1H683R385G12032.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:58:19Z","timestamp":1761515899000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X20356615"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["S1530891X20356615"],"URL":"https:\/\/doi.org\/10.4158\/ep14243.or","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"DPP-4 Inhibitor Therapy in Patients after Pancreatic Transplant","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4158\/EP14243.OR","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}